PHOTO
British manufacturer Medezine – who develop high quality medical equipment, primarily focused on medical saws, scissors and instruments – will be among the delegation of pioneering UK HealthTech companies joining the UK Pavilion at Arab Health 2022 (24 – 27 January 2022) where they are launching their innovative new range of medical saws.
Medezine’s new product range has been designed to focus on qualities that are critical to clinicians and the patient experience. Loud cast saws are known to contribute to anxiety in children and the new Medecast Cast Saws feature an ‘Anti’ noise design, making the device less intimidating for adults and children.
The unique teeth configuration and blade coating also help to reduce heat generation in use, supporting reduced patient burns and improved comfort. In addition, the device is designed to enhance patient safety, featuring a low voltage hand piece, while improved blade visibility means clinicians benefit from increased accuracy and control of procedure, leading to less patient time in practice. To make the device even safer, the innovative hood and vacuum design reduces the risk of dust inhalation.
For clinicians, the device also features an ergonomic slimline grip for improved comfort, while the lightweight design enables reduced hand stress. A unique castor base and plastic vacuum further supports improved light weight maneuverability and balance, reducing the risk of tipping, making the device easier to clean and improving its durability. In additional, the special blade coating can prolong life and reduce heat build-up, while the blades themselves can be changed without the use of tools using quick release and quick locking.
Peter Carroll, Director of Medezine said: “As a company we are committed to developing products tailored to the changing clinical demands of advanced modern healthcare, with patient safety at the heart of all of our products. Following significant customer and clinical research we are excited to be launching our new innovative Cast Saw range, as part of the ABHI UK Pavilion at Arab Health 2022. The new range is designed with enhanced ergonomic features, unique blade control and visibility, and quieter and reduced vibration in use, with unique benefits for both patients and clinicians. We look forward to making new connections at the event, while being supported in our goals by the ABHI team.”
For over 30 years Medezine has been a market leading manufacturer of high-quality medical equipment, specialising in comprehensive product ranges related to the fracture clinic and cast removal markets, in addition to autopsy markets. With research and development at the heart of what they do, the company is constantly investing in new products and innovations using the latest design technologies.
2021 saw the launch of two new global brands for Medezine, and 2022 will bring the company’s most ambitious launch to date with the release of the new innovative Cast Saw and Autopsy Saw ranges as part of the new brand Medecast, which captures 30 years of experience and innovation to deliver enhanced patient and user safety, tailored to global clinical needs.
At Arab Health 2022 – which will feature over 3,500 exhibitors from 60 countries – visitors will be able to see the new range of Medecast Cast Saws, which have been designed specifically with the patient and professional as priority, underpinned by the company’s commitment to patient safety.
Paul Benton, Managing Director, International at the ABHI added: “We are delighted that Medezine have chosen to launch their new, innovative range of cast saws on the ABHI UK Pavilion. The company is committed to developing innovations that prioritise the specific needs of patients and clinicians worldwide, and we look forward to supporting them in their vision at Arab Health 2022.”
Partnering with specialist healthcare distributors, Medezine has exported globally for over 30 years. The company has successfully partnered with industry societies, universities and leading professionals to enhance clinical excellence. Medezine are committed to manufacturing high quality products and maintains ISO 13485 accreditation, with all products fully compliant with European quality standards.
Arab Health 2022 is taking place from 24 – 27 January 2022 at the Dubai World Trade Centre. Throughout the show, Medezine will be located on the ABHI UK Pavilion –Hall 2 H2656.
For more information, visit https://www.medezine.co.uk/
-Ends-
About ABHI
ABHI is the UK’s leading industry association for health technology (HealthTech).
ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is now the largest employer in the broader Life Sciences sector, employing 138,100 people in 4,140 companies, with a combined turnover of £27.6bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 320 members account for approximately 80% of the sector by value.
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
